Open-label Study to Evaluate Metreleptin in Children Under 6 Years of Age With Generalised Lipodystrophy

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(12 sites)

Belgium

UZ Leuven, Leuven

France

Hôpital Necker - Enfants Malades, Paris

Assistance Publique-Hopitaux de Paris (AP-HP) - Hopital Universitaire Robert-Debre, Paris

Germany

Universitätsklinikum Hamburg-Eppendorf, Hamburg

Universitaetsklinikum Ulm - Klinik fuer Kinder- und Jugendmedizin, Ulm

Italy

IRCCS Ospedale Pediatrico Bambino Gesù, Chieti

Azienda Ospedaliera Universitaria "Federico II", Naples

Azienda Ospedaliero Universitaria Maggiore della Carità di Novara, Novara

Azienda Ospedaliero-Universitaria di Parma, Parma

Azienda Ospedaliero Universitaria Pisana, Pisa

IRCCS Ospedale Pediatrico Bambino Gesù, Rome

Ospedale Filippo Del Ponte Varese - ASST Sette Laghi, Varese